Clinical Trial Update: Treatment of Postoperative Hypoparathyroidism Using Cultured Allogenic Parathyroid Cells [Phase 1, Phase 2]

View source ↗

Summary

Early-stage trial evaluating cultured allogenic parathyroid cell therapy for postoperative hypoparathyroidism; phase 1/2 with unknown status.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Postoperative Hypoparathyroidism

Drugs mentioned

• Cultured allogenic parathyroid cells

Snippet

Sponsor: Institute of Biophysics and Cell Engineering of National Academy of Sciences of Belarus | Conditions: Postoperative Hypoparathyroidism | Phase 1, Phase 2 | Status: UNKNOWN